v3.24.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2024
Oct. 31, 2023
Current assets:    
Cash and cash equivalents $ 998 $ 915
Short-term investments 22,800 22,929
Receivables 391 270
Prepaid expenses and other current assets 1,030 1,242
Total current assets 25,219 25,356
Operating lease right-of-use asset 153 166
Total assets 25,372 25,522
Current liabilities:    
Accounts payable 364 206
Accrued expenses 1,242 1,770
Operating lease liability 54 52
Total current liabilities 1,660 2,028
Operating lease liability, non-current 108 123
Total liabilities 1,768 2,151
Commitments and contingencies (Note 10)
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 31,754,375 and 31,145,219 shares issued and outstanding as of January 31, 2024 and October 31, 2023, respectively 318 311
Additional paid-in capital 255,738 252,222
Accumulated deficit (231,451) (228,196)
Total shareholders’ equity 24,605 24,337
Noncontrolling interest (Note 2) (1,001) (966)
Total equity 23,604 23,371
Total liabilities and equity 25,372 25,522
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash share-based compensation expenses of $489 and $505, respectively) 1,349 1,068
General and administrative expenses (including non-cash share-based compensation expenses of $771 and $558, respectively) 2,260 1,488
Total operating costs and expenses 3,609 2,556
Loss from operations (3,609) (2,556)
Interest income 319 202
Net loss (3,290) (2,354)
Less: Net loss attributable to noncontrolling interest (35) (32)
Net loss attributable to common shareholders $ (3,255) $ (2,322)
Net loss per common share attributable to common shareholders:    
Basic $ 0.10 $ 0.08
Diluted $ 0.10 $ 0.08
Weighted average common shares outstanding:    
Basic 31,446 30,921
Diluted 31,446 30,921

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.0.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (3,290) $ (2,354)
Stock option compensation to employees and directors 1,108 957
Stock options issued to consultants 56 81
Common stock issued to consultants 96 25
Amortization of operating lease right-to-use asset 13 11
Change in operating assets and liabilities:    
Receivables (121) (100)
Prepaid expenses and other current assets 212 210
Accounts payable 158 (155)
Accrued expenses (528) (651)
Operating lease liability (13) (12)
Net cash used in operating activities (2,309) (1,988)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (20,020) (7,835)
Proceeds from maturities of short-term investments 20,149 7,250
Net cash provided by (used in) investing activities 129 (585)
Cash flows from financing activities:    
Net proceeds from sale of common stock in an at-the-market offering 2,196
Proceeds from exercise of stock options 67 3
Net cash provided by financing activities 2,263 3
Net increase (decrease) in cash and cash equivalents 83 (2,570)
Cash and cash equivalents at beginning of period 915 12,360
Cash and cash equivalents at end of period $ 998 $ 9,790

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL